SEI Investments’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.38M Buy
241,289
+55,601
+30% +$319K ﹤0.01% 1790
2025
Q1
$1.52M Sell
185,688
-33,226
-15% -$271K ﹤0.01% 1738
2024
Q4
$2.06M Sell
218,914
-3,359
-2% -$31.6K ﹤0.01% 1673
2024
Q3
$2.37M Sell
222,273
-19,858
-8% -$212K ﹤0.01% 1609
2024
Q2
$2.4M Buy
242,131
+19,416
+9% +$193K ﹤0.01% 1556
2024
Q1
$2.62M Buy
222,715
+19,366
+10% +$228K ﹤0.01% 1499
2023
Q4
$2.89M Buy
203,349
+40,864
+25% +$580K ﹤0.01% 1438
2023
Q3
$1.98M Sell
162,485
-76,606
-32% -$932K ﹤0.01% 1606
2023
Q2
$3M Sell
239,091
-29,376
-11% -$369K 0.01% 1452
2023
Q1
$2.98M Sell
268,467
-45,614
-15% -$506K 0.01% 1435
2022
Q4
$3.83M Sell
314,081
-89,368
-22% -$1.09M 0.01% 1169
2022
Q3
$4.21M Sell
403,449
-59,682
-13% -$623K 0.01% 1171
2022
Q2
$4.97M Buy
463,131
+24,791
+6% +$266K 0.01% 1096
2022
Q1
$4.15M Sell
438,340
-7,342
-2% -$69.5K 0.01% 1203
2021
Q4
$5.15M Sell
445,682
-15,311
-3% -$177K 0.01% 1123
2021
Q3
$4.4M Sell
460,993
-10,092
-2% -$96.4K 0.01% 1145
2021
Q2
$4.54M Buy
471,085
+23,152
+5% +$223K 0.01% 1130
2021
Q1
$5.2M Sell
447,933
-182,668
-29% -$2.12M 0.01% 997
2020
Q4
$14.6M Buy
630,601
+504
+0.1% +$11.6K 0.04% 476
2020
Q3
$8.9M Buy
630,097
+40,617
+7% +$574K 0.03% 595
2020
Q2
$8.89M Sell
589,480
-11,834
-2% -$178K 0.03% 593
2020
Q1
$5.56M Buy
601,314
+7,702
+1% +$71.2K 0.02% 701
2019
Q4
$5.78M Buy
593,612
+256,890
+76% +$2.5M 0.02% 843
2019
Q3
$2.7M Sell
336,722
-14,940
-4% -$120K 0.01% 1200
2019
Q2
$4.39M Buy
351,662
+20,511
+6% +$256K 0.01% 992
2019
Q1
$4.5M Buy
331,151
+50,005
+18% +$680K 0.02% 963
2018
Q4
$3.4M Hold
281,146
0.01% 1083
2018
Q3
$3.4M Buy
281,146
+247,004
+723% +$2.99M 0.01% 1055
2018
Q2
$534K Buy
34,142
+33,910
+14,616% +$530K ﹤0.01% 1790
2018
Q1
$3K Hold
232
﹤0.01% 3163
2017
Q4
$3K Buy
232
+12
+5% +$155 ﹤0.01% 3037
2017
Q3
$3K Hold
220
﹤0.01% 2921
2017
Q2
$2K Buy
+220
New +$2K ﹤0.01% 2862
2015
Q4
Sell
-47,832
Closed -$669K 2574
2015
Q3
$669K Buy
+47,832
New +$669K 0.01% 1181